Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy.

Werner RA, Ilhan H, Lehner S, Papp L, Zsótér N, Schatka I, Muegge DO, Javadi MS, Higuchi T, Buck AK, Bartenstein P, Bengel F, Essler M, Lapa C, Bundschuh RA.

Mol Imaging Biol. 2018 Jul 16. doi: 10.1007/s11307-018-1252-5. [Epub ahead of print]

PMID:
30014345
2.

A Voice From the Past: Rediscovering the Virchow Node With Prostate-specific Membrane Antigen-targeted 18F-DCFPyL Positron Emission Tomography Imaging.

Werner RA, Andree C, Javadi MS, Lapa C, Buck AK, Higuchi T, Pomper MG, Gorin MA, Rowe SP, Pienta KJ.

Urology. 2018 Jul;117:18-21. doi: 10.1016/j.urology.2018.03.030. Epub 2018 Apr 4. No abstract available.

3.

SSTR-RADS Version 1.0 as a Reporting System for SSTR PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization Framework.

Werner RA, Solnes LB, Javadi MS, Weich A, Gorin MA, Pienta KJ, Higuchi T, Buck AK, Pomper MG, Rowe SP, Lapa C.

J Nucl Med. 2018 Jul;59(7):1085-1091. doi: 10.2967/jnumed.117.206631. Epub 2018 Mar 23.

PMID:
29572257
4.

Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms.

Salas Fragomeni RA, Amir T, Sheikhbahaei S, Harvey SC, Javadi MS, Solnes LB, Kiess AP, Allaf ME, Pomper MG, Gorin MA, Rowe SP.

J Nucl Med. 2018 Jun;59(6):871-877. doi: 10.2967/jnumed.117.203570. Epub 2018 Mar 15.

PMID:
29545375
5.

Impact of Novel Antidepressants on Cardiac 123I-Metaiodobenzylguanidine Uptake: Experimental Studies on SK-N-SH Cells and Healthy Rabbits.

Werner RA, Kobayashi R, Javadi MS, Köck Z, Wakabayashi H, Unterecker S, Nakajima K, Lapa C, Menke A, Higuchi T.

J Nucl Med. 2018 Jul;59(7):1099-1103. doi: 10.2967/jnumed.117.206045. Epub 2018 Mar 1.

PMID:
29496989
6.

Subcellular storage and release mode of the novel 18F-labeled sympathetic nerve PET tracer LMI1195.

Chen X, Werner RA, Lapa C, Nose N, Hirano M, Javadi MS, Robinson S, Higuchi T.

EJNMMI Res. 2018 Feb 6;8(1):12. doi: 10.1186/s13550-018-0365-9.

7.

Complete Response to Single-agent Palbociclib in Metastatic Breast Cancer: A Case Report.

Yeruva SLH, Javadi MS, Stearns V.

Clin Breast Cancer. 2018 Jun;18(3):e277-e280. doi: 10.1016/j.clbc.2017.12.008. Epub 2017 Dec 21. No abstract available.

PMID:
29398467
8.

99mTc-sestamibi SPECT/CT for the characterization of renal masses: a pictorial guide.

Campbell SP, Tzortzakakis A, Javadi MS, Karlsson M, Solnes LB, Axelsson R, Allaf ME, Gorin MA, Rowe SP.

Br J Radiol. 2018 Apr;91(1084):20170526. doi: 10.1259/bjr.20170526. Epub 2018 Feb 27. Review.

PMID:
29271233
9.

Functional Renal Imaging with 2-Deoxy-2-18F-Fluorosorbitol PET in Rat Models of Renal Disorders.

Werner RA, Wakabayashi H, Chen X, Hirano M, Shinaji T, Lapa C, Rowe SP, Javadi MS, Higuchi T.

J Nucl Med. 2018 May;59(5):828-832. doi: 10.2967/jnumed.117.203828. Epub 2017 Dec 14.

PMID:
29242399
10.

Use of quantitative SPECT/CT reconstruction in 99mTc-sestamibi imaging of patients with renal masses.

Jones KM, Solnes LB, Rowe SP, Gorin MA, Sheikhbahaei S, Fung G, Frey EC, Allaf ME, Du Y, Javadi MS.

Ann Nucl Med. 2018 Feb;32(2):87-93. doi: 10.1007/s12149-017-1222-z. Epub 2017 Dec 6.

PMID:
29214562
11.

Decreased occipital lobe metabolism by FDG-PET/CT: An anti-NMDA receptor encephalitis biomarker.

Probasco JC, Solnes L, Nalluri A, Cohen J, Jones KM, Zan E, Javadi MS, Venkatesan A.

Neurol Neuroimmunol Neuroinflamm. 2017 Nov 15;5(1):e413. doi: 10.1212/NXI.0000000000000413. eCollection 2018 Jan.

12.

Unilateral Submandibular Gland Atrophy and Sialolithiasis Diagnosed on 99mTc-MIBI SPECT/CT in a Patient With Primary Hyperparathyroidism.

Pattanayak P, Santhanam P, Javadi MS, Solnes LB, Rowe SP.

Clin Nucl Med. 2017 Dec;42(12):939-940. doi: 10.1097/RLU.0000000000001863.

PMID:
29036000
13.

Appearance of Adrenal Myelolipomas on 2-deoxy-2-(18F) fluoro-D-glucose Positron Emission Tomography-Computed Tomography.

Rowe SP, Javadi MS, Solnes LB, Fishman EK.

World J Nucl Med. 2017 Oct-Dec;16(4):271-274. doi: 10.4103/1450-1147.215499.

14.

Predictive Value of 18F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib.

Werner RA, Schmid JS, Higuchi T, Javadi MS, Rowe SP, Märkl B, Aulmann C, Fassnacht M, Kroiss M, Reiners C, Buck AK, Kreissl MC, Lapa C.

J Nucl Med. 2018 May;59(5):756-761. doi: 10.2967/jnumed.117.199778. Epub 2017 Oct 12.

PMID:
29025983
15.

Correlation of 99mTc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expression.

Rowe SP, Gorin MA, Solnes LB, Ball MW, Choudhary A, Pierorazio PM, Epstein JI, Javadi MS, Allaf ME, Baras AS.

EJNMMI Res. 2017 Oct 2;7(1):80. doi: 10.1186/s13550-017-0329-5.

16.

New horizons in cardiac innervation imaging: introduction of novel 18F-labeled PET tracers.

Kobayashi R, Chen X, Werner RA, Lapa C, Javadi MS, Higuchi T.

Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2302-2309. doi: 10.1007/s00259-017-3828-8. Epub 2017 Sep 13. Review.

PMID:
28905088
17.

Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted 18F-DCFPyL in peripheral ganglia.

Werner RA, Sheikhbahaei S, Jones KM, Javadi MS, Solnes LB, Ross AE, Allaf ME, Pienta KJ, Lapa C, Buck AK, Higuchi T, Pomper MG, Gorin MA, Rowe SP.

Ann Nucl Med. 2017 Nov;31(9):696-702. doi: 10.1007/s12149-017-1201-4. Epub 2017 Aug 22.

18.

Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging.

Sheikhbahaei S, Afshar-Oromieh A, Eiber M, Solnes LB, Javadi MS, Ross AE, Pienta KJ, Allaf ME, Haberkorn U, Pomper MG, Gorin MA, Rowe SP.

Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2117-2136. doi: 10.1007/s00259-017-3780-7. Epub 2017 Aug 1. Review.

PMID:
28765998
19.

Prostate-Specific Membrane Antigen-Targeted Imaging With [18F]DCFPyL in High-Grade Gliomas.

Salas Fragomeni RA, Menke JR, Holdhoff M, Ferrigno C, Laterra JJ, Solnes LB, Javadi MS, Szabo Z, Pomper MG, Rowe SP.

Clin Nucl Med. 2017 Oct;42(10):e433-e435. doi: 10.1097/RLU.0000000000001769.

20.

Prostate Specific Membrane Antigen Targeted 18F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center Study.

Gorin MA, Rowe SP, Patel HD, Vidal I, Mana-Ay M, Javadi MS, Solnes LB, Ross AE, Schaeffer EM, Bivalacqua TJ, Partin AW, Pienta KJ, Szabo Z, De Marzo AM, Pomper MG, Allaf ME.

J Urol. 2018 Jan;199(1):126-132. doi: 10.1016/j.juro.2017.07.070. Epub 2017 Jul 20.

21.

Incidental pulmonary arterial dilatation and coronary calcifications in patients with hypertension and normal findings on myocardial perfusion technetium-99m sestamibi single-photon emission computed tomography.

Santhanam P, Marcus C, Solnes LB, Kral BG, Javadi MS, Rowe SP.

J Clin Hypertens (Greenwich). 2017 Oct;19(10):1054-1055. doi: 10.1111/jch.13043. Epub 2017 Jun 23. No abstract available.

22.

Abnormal brain metabolism on FDG-PET/CT is a common early finding in autoimmune encephalitis.

Probasco JC, Solnes L, Nalluri A, Cohen J, Jones KM, Zan E, Javadi MS, Venkatesan A.

Neurol Neuroimmunol Neuroinflamm. 2017 May 11;4(4):e352. doi: 10.1212/NXI.0000000000000352. eCollection 2017 Jul.

23.

Characterization of indeterminate renal masses with molecular imaging: how do we turn potential into reality?

Rowe SP, Javadi MS, Allaf ME, Gorin MA.

EJNMMI Res. 2017 Dec;7(1):34. doi: 10.1186/s13550-017-0277-0. Epub 2017 Apr 12. No abstract available.

24.

Re: Increased 18F-2-Fluorodeoxysorbitol (18F-FDS) Activity in a Pituitary Spindle Cell Carcinoma.

Javadi MS, Ordonez AA, Jain SK.

Clin Nucl Med. 2017 Aug;42(8):649. doi: 10.1097/RLU.0000000000001644. No abstract available.

PMID:
28319504
25.

Diagnostic Value of 18F-FDG PET/CT Versus MRI in the Setting of Antibody-Specific Autoimmune Encephalitis.

Solnes LB, Jones KM, Rowe SP, Pattanayak P, Nalluri A, Venkatesan A, Probasco JC, Javadi MS.

J Nucl Med. 2017 Aug;58(8):1307-1313. doi: 10.2967/jnumed.116.184333. Epub 2017 Feb 16.

PMID:
28209905
26.

Childhood recurrent abdominal pain and Helicobacter pylori infection, Islamic Republic of Iran.

Alimohammadi H, Fouladi N, Salehzadeh F, Alipour SA, Javadi MS.

East Mediterr Health J. 2017 Feb 1;22(12):860-864.

PMID:
28181660
27.

Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal Masses.

Sheikhbahaei S, Jones CS, Porter KK, Rowe SP, Gorin MA, Baras AS, Pierorazio PM, Ball MW, Higuchi T, Johnson PT, Solnes LB, Epstein JI, Allaf ME, Javadi MS.

Clin Nucl Med. 2017 Apr;42(4):e188-e193. doi: 10.1097/RLU.0000000000001534.

PMID:
28114223
28.

Evaluation of a Large Renal Mass Using 99mTc-MIBI SPECT/CT in a Patient With Chronic Kidney Disease.

Rowe SP, Gorin MA, Javadi MS, Allaf ME.

Clin Nucl Med. 2017 Mar;42(3):e166-e167. doi: 10.1097/RLU.0000000000001533.

PMID:
28072625
29.

Plasma Fluoride Level and Femoral Bone Mineral Density in Post-Menopausal Women.

Santhanam P, Rowe SP, Solnes LB, Javadi MS.

Int J Occup Environ Med. 2017 Jan;8(1):56-57. doi: 10.15171/ijoem.2017.978. No abstract available.

30.

Whole-Body 18F-FDG PET and 18F-FDG PET/CT in Patients with Suspected Paraneoplastic Syndrome: A Systematic Review and Meta-Analysis of Diagnostic Accuracy.

Sheikhbahaei S, Marcus CV, Fragomeni RS, Rowe SP, Javadi MS, Solnes LB.

J Nucl Med. 2017 Jul;58(7):1031-1036. doi: 10.2967/jnumed.116.183905. Epub 2016 Dec 15. Review.

31.

Impact of tissue photon attenuation in small animal cardiac PET imaging.

Hayakawa N, Yamane T, Arias-Loza AP, Shinaji T, Wakabayashi H, Lapa C, Werner RA, Javadi MS, Pelzer T, Higuchi T.

Int J Cardiol. 2017 Jan 15;227:257-260. doi: 10.1016/j.ijcard.2016.11.119. Epub 2016 Nov 9.

PMID:
27839818
32.

Factors Affecting Quality of Emergency Service in Iran's Military Hospitals: A Qualitative Study.

Zaboli R, Shokri M, Javadi MS, Teymourzadeh E, Ameryoun A.

Electron Physician. 2016 Sep 20;8(9):2990-2997. eCollection 2016 Sep.

33.

18F-FDG PET/CT Imaging of Cauda Equina Syndrome Secondary to Leptomeningeal Metastatic Breast Cancer.

Solnes LB, Javadi MS, Rowe SP.

Clin Nucl Med. 2016 Nov;41(11):e485-e486.

PMID:
27607169
34.

Assessment of coronary flow reserve using a combination of planar first-pass angiography and myocardial SPECT: Comparison with myocardial (15)O-water PET.

Nose N, Fukushima K, Lapa C, Werner RA, Javadi MS, Taki J, Higuchi T.

Int J Cardiol. 2016 Nov 1;222:209-212. doi: 10.1016/j.ijcard.2016.07.183. Epub 2016 Jul 29.

PMID:
27497096
35.

Posttreatment FDG PET/CT in predicting survival of patients with ovarian carcinoma.

Chu LC, Tsai HL, Wang H, Crandall J, Javadi MS, Wahl RL.

EJNMMI Res. 2016 Dec;6(1):42. doi: 10.1186/s13550-016-0194-7. Epub 2016 May 20.

36.

Initial Preclinical Evaluation of 18F-Fluorodeoxysorbitol PET as a Novel Functional Renal Imaging Agent.

Wakabayashi H, Werner RA, Hayakawa N, Javadi MS, Xinyu C, Herrmann K, Rowe SP, Lapa C, Higuchi T.

J Nucl Med. 2016 Oct;57(10):1625-1628. Epub 2016 Mar 24.

37.

PSMA-Based Detection of Prostate Cancer Bone Lesions With ¹⁸F-DCFPyL PET/CT: A Sensitive Alternative to (⁹⁹m)Tc-MDP Bone Scan and Na¹⁸F PET/CT?

Rowe SP, Mana-Ay M, Javadi MS, Szabo Z, Leal JP, Pomper MG, Pienta KJ, Ross AE, Gorin MA.

Clin Genitourin Cancer. 2016 Feb;14(1):e115-8. doi: 10.1016/j.clgc.2015.09.011. Epub 2015 Sep 30. No abstract available.

38.

Detection of 18F-FDG PET/CT Occult Lesions With 18F-DCFPyL PET/CT in a Patient With Metastatic Renal Cell Carcinoma.

Rowe SP, Gorin MA, Hammers HJ, Pomper MG, Allaf ME, Javadi MS.

Clin Nucl Med. 2016 Jan;41(1):83-5. doi: 10.1097/RLU.0000000000000995.

39.

Prospective Evaluation of (99m)Tc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors.

Gorin MA, Rowe SP, Baras AS, Solnes LB, Ball MW, Pierorazio PM, Pavlovich CP, Epstein JI, Javadi MS, Allaf ME.

Eur Urol. 2016 Mar;69(3):413-6. doi: 10.1016/j.eururo.2015.08.056. Epub 2015 Sep 18.

PMID:
26386607
40.

Sympathetic nerve damage and restoration after ischemia-reperfusion injury as assessed by (11)C-hydroxyephedrine.

Werner RA, Maya Y, Rischpler C, Javadi MS, Fukushima K, Lapa C, Herrmann K, Higuchi T.

Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):312-8. doi: 10.1007/s00259-015-3171-x. Epub 2015 Aug 21.

PMID:
26290424
41.

Radionuclide imaging of neurohormonal system of the heart.

Chen X, Werner RA, Javadi MS, Maya Y, Decker M, Lapa C, Herrmann K, Higuchi T.

Theranostics. 2015 Feb 15;5(6):545-58. doi: 10.7150/thno.10900. eCollection 2015. Review.

42.

Initial experience using 99mTc-MIBI SPECT/CT for the differentiation of oncocytoma from renal cell carcinoma.

Rowe SP, Gorin MA, Gordetsky J, Ball MW, Pierorazio PM, Higuchi T, Epstein JI, Allaf ME, Javadi MS.

Clin Nucl Med. 2015 Apr;40(4):309-13. doi: 10.1097/RLU.0000000000000670.

43.

Interaction of alcohols with the calcite surface.

Bovet N, Yang M, Javadi MS, Stipp SL.

Phys Chem Chem Phys. 2015 Feb 7;17(5):3490-6. doi: 10.1039/c4cp05235h. Epub 2014 Dec 23.

PMID:
25533590
44.

Small-animal PET imaging of isolated perfused rat heart.

Yamane T, Park MJ, Richter D, Nekolla SG, Javadi MS, Lapa C, Samnick S, Buck AK, Herrmann K, Higuchi T.

J Nucl Med. 2014 Mar;55(3):495-9. doi: 10.2967/jnumed.113.129429. Epub 2014 Jan 30.

45.

Discrepant uptake of the radiolabeled norepinephrine analogues hydroxyephedrine (HED) and metaiodobenzylguanidine (MIBG) in rat hearts.

Rischpler C, Fukushima K, Isoda T, Javadi MS, Dannals RF, Abraham R, Wahl R, Bengel FM, Higuchi T.

Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1077-83. doi: 10.1007/s00259-013-2393-z. Epub 2013 Mar 29.

PMID:
23539177
46.

Targeting of endothelin receptors in the healthy and infarcted rat heart using the PET tracer 18F-FBzBMS.

Higuchi T, Rischpler C, Fukushima K, Isoda T, Xia J, Javadi MS, Szabo Z, Dannals RF, Mathews WB, Bengel FM.

J Nucl Med. 2013 Feb;54(2):277-82. doi: 10.2967/jnumed.112.106096. Epub 2013 Jan 11.

47.

Impaired global myocardial flow dynamics despite normal left ventricular function and regional perfusion in chronic kidney disease: a quantitative analysis of clinical 82Rb PET/CT studies.

Fukushima K, Javadi MS, Higuchi T, Bravo PE, Chien D, Lautamäki R, Merrill J, Nekolla SG, Bengel FM.

J Nucl Med. 2012 Jun;53(6):887-93. doi: 10.2967/jnumed.111.099325. Epub 2012 May 4.

48.

Transient ischemic dilation ratio in 82Rb PET myocardial perfusion imaging: normal values and significance as a diagnostic and prognostic marker.

Rischpler C, Higuchi T, Fukushima K, Javadi MS, Merrill J, Nekolla SG, Bravo PE, Bengel FM.

J Nucl Med. 2012 May;53(5):723-30. doi: 10.2967/jnumed.111.097600. Epub 2012 Apr 9.

49.

Stable delineation of the ischemic area by the PET perfusion tracer 18F-fluorobenzyl triphenyl phosphonium after transient coronary occlusion.

Higuchi T, Fukushima K, Rischpler C, Isoda T, Javadi MS, Ravert H, Holt DP, Dannals RF, Madar I, Bengel FM.

J Nucl Med. 2011 Jun;52(6):965-9. doi: 10.2967/jnumed.110.085993. Epub 2011 May 13.

50.

Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82Rb PET perfusion imaging.

Fukushima K, Javadi MS, Higuchi T, Lautamäki R, Merrill J, Nekolla SG, Bengel FM.

J Nucl Med. 2011 May;52(5):726-32. doi: 10.2967/jnumed.110.081828. Epub 2011 Apr 15.

Supplemental Content

Loading ...
Support Center